Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study

Cephalalgia

Volumn 25, Issue 1, 2005, Pages 12-15

  Katsarava, Z ^a   Muessig, M ^a   Dzagnidze, A ^a   Fritsche, G ^a   Diener, H C ^a   Limmroth, Volker ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Medication overuse headache; Relapse; Triptans

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; ERGOTAMINE; NARATRIPTAN; SEROTONIN AGONIST; ZOLMITRIPTAN;

ADULT; ARTICLE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RELAPSE; TENSION HEADACHE; TREATMENT OUTCOME;

ADULT; AGED; ANALGESICS; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 12444335959     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00789.x     Document Type: Article

References (17)

1. Headache Classification Subcommittee of the IHS. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24 Suppl 1:1-160.
2. Tfelt-Hansen P, Krabbe AA. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981; 1:29-32.
3. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987; 7:15-9.
4. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic daily headache: long-term results of withdrawal therapy. Neurology 1989; 236:9-14.
5. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989; 29:510-4.
6. Pini L, Bigarelli M, Vitale G, Sternieri E. Headaches associated with chronic use of analgesics: a theraputic approach. Headache 1996; 36:433-9.
7. Linton-Dahlöf P, Linde M, Dahlöf C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000; 20:658-62.
8. Pini LA, Cicero AFG, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001; 21:878-83.
9. Katsarava Z, Limmroth V, Finke M, Diener H, Fritsche G. Rate and predictors for relapse in medication overuse headache: a one year prospective study. Neurology 2003; 60:1682-3.
10. Schnider P, Aull S, Baumgartner C, Merterer A, Wöber C, Zeiler K et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996; 16:481-5.
11. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Hussted IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19:44-9.
12. Tribl GG, Schnider P, Wöber C, Aull S, Auterith A, Zeiler K et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001; 21:691-6.
13. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001; 45:229-35.
14. Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002; 42:483-90.
15. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener H. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59:1011-4.
16. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57:1694-8.
17. Limmroth V, Kazarawa S, Fritsche G, Diener HC. Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 1999; 353:378.